IDELVION albutrepenonacog alfa 3500 IU powder (and diluent) for injection

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

即購入

公開評価報告書 公開評価報告書 (PAR)
12-01-2021

有効成分:

Factor IX, Quantity: 3500 IU

から入手可能:

CSL Behring Australia Pty Ltd

医薬品形態:

Solution

構図:

Excipient Ingredients:

投与経路:

Intravenous

パッケージ内のユニット:

3500 IU

処方タイプ:

Not scheduled. Not considered by committee

適応症:

IDELVION is indicated in all patients with haemophilia B for:,? Routine prophylaxis to prevent or reduce the frequency of bleeding episodes,? Control and prevention of bleeding episodes,? Control and prevention of bleeding in the perioperative setting.

製品概要:

Visual Identification: Clear solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store between 2 - 25 degrees celsius; Container Closure: Neither child resistant closure nor restricted flow insert

認証ステータス:

Registered

承認日:

2020-11-19